Acknowledgements
The study has been conducted in accordance with the Declaration of Helsinki. The study was approved by the Institutional Review Board of Renji Hospital affiliated with the School of Medicine, Shanghai Jiao Tong University (Ethics Board approval number: Renji Ethics [2017]091).
Funding
This study was supported by the three-year action project of Shanghai Hospital Development Centre (no. SHDC2020CR6008).
Author information
Authors and Affiliations
Contributions
XW, CY, TT: protocol/project development, data analysis, manuscript writing/editing, supervision; XW: obtaining funding; WX, ZJ, CW: data collection or management, data analysis, manuscript writing/editing; CW, LD, HY: data collection or management.
Corresponding authors
Ethics declarations
Disclosures
The authors declare no conflicts of interest.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, X., Zhou, J., Chen, W. et al. ASO Visual Abstract: Retroperitoneoscopic Clampless Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors. Ann Surg Oncol 31, 688–689 (2024). https://doi.org/10.1245/s10434-023-14385-4
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14385-4